NUFIP1 (Nuclear FMRP Interacting Protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes

Experimental Cell Research

Volumn 289, Issue 1, 2003, Pages 95-107

  Bardoni, Barbara ^a   Willemsen, Rob ^b   Weiler, Ivan Jeanne ^c   Schenck, Annette ^a   Severijnen, Lies Anne ^b   Hindelang, Colette ^a   Lalli, Enzo ^a   Mandel, Jean Louis ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Fragile X syndrome; Mental retardation; Nuclear export signal (NES); Nuclear matrix; RNA binding protein; Synaptoneurosomes

Indexed keywords

EXPORTIN 1; FRAGILE X MENTAL RETARDATION PROTEIN; PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; FRAGILE X SYNDROME; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; RIBOSOME;

NES;

EID: 0041534394     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00222-2     Document Type: Article

References (61)

1. Hagerman R.J., Cronister A. Fragile X syndrome diagnosis, treatment and research . second ed: 1996;Johns Hopkins University Press, Baltimore.
2. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice maturation and pruning deficits . Proc. Natl. Acad. Sci. USA. 94:1997;5401-5404.
3. Irwin S.A., Galvez R., Greenough W.T. Dendritic spine structural anomalies in Fragile-X mental retardation syndrome. Cereb. Cortex. 10:2000;1038-1044.
4. Greenough W.T., Klintsova A.Y., Irwin S.A., Galvez R., Bates K.E., Weiler I.J. Synaptic regulation of protein synthesis and the fragile X protein. Proc. Natl. Acad. Sci. USA. 98:2001;7101-7106.
5. Devys D., Lutz Y., Rouyer N., Bellocq J.P., Mandel J.L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4:1993;335-340.
6. Kiledjian M., Dreyfuss G. Primary structure and binding activity of the hnRNP U protein binding RNA through RGG box . EMBO J. 11:1992;2655-2664.
7. Siomi H., Matunis M.J., Michael W.M., Dreyfuss G. The pre-mRNA binding K protein contains a novel evolutionary conserved motif. Nucl. Acids Res. 21:1993;1193-1198.
8. Fridell R.A., Benson R.E., Hua J., Bogerd H.P., Cullen B.R. A nuclear role for the Fragile X mental retardation protein. EMBO J. 15:1996;5408-5414.
9. Eberhart D.E., Malter H.E., Feng Y., Warren S.T. The Fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5:1996;1083-1091.
10. Bardoni B., Sittler A., Shen Y., Mandel J.L. Analysis of domains affecting intracellular localization of the FMRP protein. Neurobiol. Disease. 4:1997;329-336.
11. Tamanini F., Bontekoe C., Bakker C.E., van Unen L., Anar B., Willemsen R., Yoshida M., Galjiaard H., Oostra B.A., Hoogeveen A.T. Different targets for the fragile X related proteins revealed by distinct nuclear localization. Hum. Mol. Genet. 8:1999;863-869.
12. Feng Y., Gutekunst C.A., Eberhart D.E., Yi H., Warren S.T., Hersch S.M. Fragile X mental retardation protein nucleocytoplasmic shuttling and association with somatodendritic ribosomes . J. Neurosci. 17:1997;1539-1547.
13. Bakker C.E., de Diego Otero Y., Bontekoe C., Raghoe P., Luteijn T., Hoogeven A.T., Oostra B.A., Willemsen R. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp. Cell Res. 258:2000;162-170.
14. + mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6:1997;1465-1472.
15. Feng Y., Absher D., Eberhart D.E., Brown V., Malter H.E., Warren S.T. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1:1997;109-118.
16. Weiler I.J., Irwin S.A., Klintsova A.Y., Spencer C.M., Brazelton A.D., Miyashiro K., Comery T.A., Patel B., Eberwine J., Greenough W.T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA. 94:1997;5395-5400.
17. De Diego Otero Y., Severijnen L.A., van Cappellen G., Oostra B., Willemsen R. Transport of fragile X mental retardation protein via granules in neurites of PC12 cell. Mol.Cell.Biol. 22:2002;8332-8341.
18. Ashley C.T. Jr., Wilkinson K.D., Reines D., Warren S.T. FMR1 protein conserved RNP family domains and selective RNA binding . Science. 262:1993;563-566.
19. Ceman S., Brown V., Warren S.T. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X related proteins as components of the complex. Mol. Cell. Biol. 19:1999;7925-7932.
20. Schaeffer C., Bardoni B., Mandel J.L., Ehresmann B., Ehresmann C., Moine H. The Fragile X mental retardation protein interacts specifically with its own mRNA via a purine-quartet structure. EMBO J. 20:2001;4803-4813.
21. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 107:2001;489-499.
22. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 107:2001;477-487.
23. Miyashiro K.Y., Beckel-Mitchener A., Purk T.P., Becker K.G., Barret T., Carbonetto S., Weiler I.J., Greenough W.T., Eberwine J. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron. 37:2003;417-431.
24. Laggerbauer B., Ostareck D., Keidel E.-M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10:2001;329-338.
25. Li Z., Zhang Y., Ku L., Wilkinson K.D., Warren S.T., Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucl. Acids Res. 29:2001;2276-2283.
26. Bardoni B., Mandel J.L. Advances in understanding of fragile X pathogenesis and FMRP function, and identification of X linked mental retardation genes. Curr. Opin. Gen. Dev. 12:2002;284-293.
27. Siomi M.C., Siomi H., Sauer W.H., Srinivasan S., Nussbaum R.L., Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14:1995;2401-2408.
28. Zhang Y., O'Connor J.P., Siomi M.C., Srinivasan S., Dutra A., Nussbaum R.L., Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 14:1995;53-60.
29. Bardoni B., Schenck A., Mandel J.L. A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein. Hum. Mol. Genet. 8:1999;2557-2566.
30. Ceman S., Nelson R., Warren S.T. Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particles. Biochem. Biophys. Res. Comm. 279:2000;904-908.
31. Ohashi S., Koike K., Omori A., Ichinose S., Ohara S., Kobayashi S., Sato T.A., Anzai K. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem. 277:2002;37804-37810.
32. Schenck A., Bardoni B., Moro A., Bagni C., Mandel J.L. A highly conserved protein family interacting with the fragile X Mental Retardation Protein and displaying selective interactions with the FMRP related proteins FXR1P and FXR2P. Proc. Natl. Acad. Sci. USA. 98:2001;8844-8849.
33. Bardoni B., Schenck A., Mandel J.L. The fragile X mental retardation protein. Brain Res. Bull. 56:2001;375-382.
34. He D., Nickerson A.D., Penman S. Core filaments of the nuclear matrix. J. Cell Biol. 110:1990;569-580.
35. Reyes J.C., Muchardt C., Yaniv M. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol. 137:1997;263-274.
36. Mirkovitch J., Mirault M.-E., Laemmli U.K. Organization of the higher-order chromatin loop specific DNA attachment sites on nuclear scaffold . Cell. 39:1984;223-232.
37. Brasch K. Fine structure and localization of the nuclear matrix in situ. Exp. Cell Res. 140:1982;161-171.
38. Huang S.Y., Garrard W.T. Electrophoretic analyses of nucleosomes and other proteins DNA-complexes. Methods Enzymol. 170:1989;116-142.
39. Remboutsika E., Lutz Y., Gansmuller A., Vonesch J.-L., Losson R., Chambon P. The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin. J. Cell Sci. 112:1999;1671-1683.
40. Pyle J.L., Kavalali E.T., Choi S., Tsien R.W. Visualization of synaptic activity in hippocampal slices with FM1-43 enabled by fluorescence quenching. Neuron. 24:1999;803-808.
41. Harlow E., Lane D. Antibodies a laboratory manual . 1988;Cold Spring Harbor Laboratory Press, New York.
42. Le Douarin B., vom Baur E., Zechel C., Heery D., Heine M., Vivat V., Losson R., Chambon P. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators). Phil. Trans. R. Soc. Lond. 351:1996;569-578.
43. Jackson D.A., Hassan B., Errington R., Cook P.R. Visualization of focal sites of transcription within human nuclei. EMBO J. 12:1993;1059-1065.
44. Wansink D.G., Schul W., van der Kraan I., van Steensel B., van Driel R., de Jong L. Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus. J. Cell Biol. 122:1993;283-293.
45. Wei X., Somanathan S., Samarabandu J., Berezney R. Three dimensional visualization of transcription sites and their association with splicing factor-rich nuclear speckles. J. Cell Biol. 146:1999;543-558.
46. Lalli E., Ohe K., Hindelang C., Sassone-Corsi P. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol. Cell. Biol. 20:2000;4910-4921.
47. Rose S.M., Garrard W.T. Differentiation-dependent chromatin alterations precede and accompany transcription of immunoglobulin light chain genes. J. Biol. Chem. 259:1984;8534-8544.
48. Kirov N., Tsanev R. Activated murine alpha-globin gene is not preferentially associated with the nuclear matrix. Int. J. Biochem. 18:1986;155-159.
49. Bernhard W. A new staining procedure for electron microscopical analysis. J. Ultrastruct. Res. 27:1969;250-265.
50. Fakan S. Perichromatin fibrils are in situ forms of nascent transcripts. Trends Cell Biol. 4:1994;86-90.
51. Betz W.J., Bewick G.S., Ridge R.M. Intracellular movements of fluorescently labeled synaptic vesicles in frog motor nerve erminals during nerve stimulation. Neuron. 9:1992;805-813.
52. Meffert M.K., Premack B.A., Schulman H. Inhibition of hippocampal heme oxygenase, nitric oxide synthetase and long-term potentiation by metalloporphyrins. Neuron. 12:1994;1235-1244.
53. Ahmari S.E., Buchanan J., Smith S.J. Assembly of presynaptic active zones from cytoplasmic transport packets. Nat. Neurosci. 3:2000;415-417.
54. Görlich D. Transport into and out of the cell nucleus. EMBO J. 17:1998;2721-2727.
55. Henderson B.R., Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signal. Exp. Cell Res. 256:2000;213-224.
56. Rosorius O., Fries B., Stauber R.H., Hirschmann N., Bevec D., Hauber J. Human ribosomal protein L5 contains defined nuclear localization and export signals. J. Biol. Chem. 275:2000;12061-12068.
57. Affolter M., Marty T., Vigano M.A. Balancing import and export in development. Genes Dev. 13:1999;913-915.
58. Tamanini F., Willemsen R., van Unen L., Bontekoe C., Galjaard H., Oostra B.A., Hoogeveen A.T. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet. 6:1997;1315-1322.
59. FMR1 knockout mice a model to study fragile X mental retardation . Cell. 78:1994;23-33.
60. Visa N., Alzhanova-Ericsson A.L., Sun L., Kiseleva E., Björkroth B., Wurtz T., Daneholt B. A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into the polysomes. Cell. 84:1996;253-264.
61. Steward O., Worley P.F. A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc. Natl. Acad. Sci. USA. 98:2001;7062-7068.